AP:PSEAboitiz Power Corp. Analysis
Data as of 2026-03-17 - not real-time
$8.35
Latest Price
8/10Risk
Risk Level: High
Executive Summary
Ampco‑Pittsburgh (AP) is trading at $8.35, which sits below its 20‑day SMA of $8.91 but comfortably above the 50‑day SMA of $7.25, suggesting a short‑term pull‑back within a broader bullish framework. The RSI of 49.97 signals a neutral momentum, while the MACD histogram is negative and the signal line is bearish, hinting at potential downside pressure. Price remains above the calculated support of $7.10 and well under the $10 resistance, yet the 30‑day volatility is an extreme 99.7% and beta exceeds 1.2, flagging high market‑related risk.
Fundamentally, the company posts 12% revenue growth but suffers a negative profit margin (‑1.2%) and a trailing EPS of ‑$0.27, compounded by a steep debt‑to‑equity ratio of 188% and a cash balance far smaller than its $140M debt load. The DCF‑derived fair value of $18.92 implies the stock is materially undervalued, though the forward PE of 36.3 versus an industry average of 29.3 suggests a premium pricing that may not be justified without an earnings turnaround.
Fundamentally, the company posts 12% revenue growth but suffers a negative profit margin (‑1.2%) and a trailing EPS of ‑$0.27, compounded by a steep debt‑to‑equity ratio of 188% and a cash balance far smaller than its $140M debt load. The DCF‑derived fair value of $18.92 implies the stock is materially undervalued, though the forward PE of 36.3 versus an industry average of 29.3 suggests a premium pricing that may not be justified without an earnings turnaround.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 5/10
Key Factors
- Price near support but MACD bearish
- Extreme short‑term volatility
- High leverage and negative earnings
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- DCF fair value indicates ~125% upside
- Revenue growth of 12% YoY
- Potential earnings recovery improving forward PE
Long Term
> 3 yearsNeutral
Model confidence: 5/10
Key Factors
- Sustained high debt‑to‑equity ratio
- Cyclical industrial sector exposure
- Need for consistent profitability to justify valuation
Key Metrics & Analysis
Financial Health
Revenue Growth12.30%
Profit Margin-1.24%
P/E Ratio36.3
ROE-4.08%
ROA1.82%
Debt/Equity187.59
P/B Ratio2.8
Op. Cash Flow$6.1M
Free Cash Flow$22.4M
Industry P/E29.3
Technical Analysis
TrendBullish
RSI50.0
Support$7.10
Resistance$10.00
MA 20$8.91
MA 50$7.25
MA 200$4.00
MACDBearish
VolumeDecreasing
Fear & Greed Index78.88
Valuation
Fair Value$18.92
GradeUndervalued
TypeBlend
Risk Assessment
Beta1.25
Volatility99.70%
Sector RiskHigh
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.